Press Releases

PUTT APPLAUDS CONNECTICUT’S NEW ANTI-CLAWBACK LAW, URGES U.S. DISTRICT COURT IN NORTH DAKOTA TO UPHOLD NEW LEGISLATION REQUIRING GREATER PBM TRANSPARENCY

July 19,2017

Pharmacists United for Truth and Transparency (PUTT) today congratulated the state of Connecticut for passing legislation that effectively makes the practice of pharmacy clawbacks by Pharmacy Benefits Managers (PBMs) illegal. Clawbacks happen when the cost of a prescription is less than the co-pay charged to the patient — the PBM “claws back” the difference, which it keeps rather than refund to the patient. For example, a $50 prescription drug co-pay on a drug that costs

$12 to fill results in a “claw back” of $38 to the PBM — not a savings for the patient. Read more…

 

PUTT CONGRATULATES NEVADA STATE SENATE ON PASSAGE OF DRUG PRICING TRANSPARENCY LAW, CALLS ON OTHER STATES TO ENACT SIMILAR LEGISLATION

June 28, 2017

Together with the Nevada Pharmacists Association, Pharmacists United for Truth and Transparency (PUTT) offered congratulations to citizens and the state legislature of Nevada for the passage of SB 539, a landmark bill requiring pricing transparency from drug manufacturers and Pharmacy Benefits Management (PBM) “middlemen” responsible for negotiating the prices patients and payers pay for those drugs. Read more…

 

PUTT LAUNCHES PBM REFORM CAMPAIGN

May 9, 2017

Pharmacists United for Truth and Transparency (PUTT) today announced the launch of #PBMReform – a campaign aimed at exposing the facts about how non-transparent Pharmacy Benefits Management companies, or PBMs, create an anti-competitive business environment that ultimately hurts patients and taxpayers by threatening small business and community pharmacies. PUTT, who is calling on Congress to demand transparency from the PBM industry, unveiled a new, multi-media campaign on its website entitled “#PBMReform” to arm patients, taxpayers and pharmacists with information and resources they need to contact their legislators about unfair PBM practices. Read more…

 

PHARMACISTS UNITED FOR TRUTH AND TRANSPARENCY ENDORSES GEORGIA PHARMACY PATIENT FAIR PRACTICES ACT, APPLAUDS STATE LEGISLATURE

March 21, 2017

Pharmacists United for Truth and Transparency (PUTT) today announced its endorsement of Georgia Senate Bill 103, The Pharmacy Patient Fair Practices Act,  and acknowledged the state legislature for its decision to put the needs and rights of the patient first. SB103 passed through both houses of the Georgia legislature and is on its way to Governor Nathan Deal for signature. Read more…

 

PHARMACIST WATCHDOG GROUP CALLS OUT DONALD TRUMP AND HILLARY CLINTON

October 17, 2016

During the second presidential debate, audience member Ken Karpowitz asked, “Affordable Care Act … is not affordable. Premiums have gone up, deductibles have gone up, copays have gone up, prescriptions have gone up, and the coverage has gone down. What will you do to bring the cost down and make coverage better?” Read more…

 

FLORIDA BASED PHARMACY LOSES CLOSE TO 330 MONTHLY PRESCRIPTIONS AFTER CVS CAREMARK CONTRACTS FLORIDA BASED MEDICAID HMO PLAN

July 20, 2016

Patients of Discount Pharmacy in Dade City, Florida were surprised to receive cautionary network restriction letters from their Medicaid HMO Plan, Staywell. The letter warned that after March 31, 2016 only the approved pharmacists listed in the letter would be covered under Staywell’s Managed Care Plan. Patients quickly noticed Discount Pharmacy was nowhere to be found on the list.  One of the co-founders of Discount Pharmacy describes that period as a flurry of confusion, “Since the restriction was enacted in April, we’ve lost approximately 326 prescriptions per month from 51 patients, because, and rightfully so, they don’t want to change their plans.”  Read more…

 

PHARMACISTS UNITED FOR TRUTH AND TRANSPARENCY DEMANDS OVERSIGHT OF THIRD PARTY PHARMACY BENEFITS MANAGEMENT COMPANIES

June 1, 2016

“Currently there is very limited industry regulation or even clarity of how PBMs conduct business,” said Teresa Stickler, Pharm D. and President of PUTT. “There is scant evidence that PBMs reduce the overall cost of prescription medications. The PBMs evolving business practices through purposeful complexities are negatively impacting patients, payors and pharmacies and ‘negotiating’ reimbursements with pharmacists that are often below the pharmacy’s cost. This and other deceptive practices are depriving independent community pharmacies and their patients the opportunity to do business fairly.” Read More…

 

ACPCN To Congress: Review FTC Failures in Prescription Drug Market
The Federal Trade Commission is Uninformed About PBM Practices That Destroy Competition
April 3, 2011
The Association of Community Pharmacists Congressional Network (ACPCN) testified at a March 29 hearing by the House Subcommittee on Intellectual Property, Competition, and the Internet that independent U.S. pharmacies lack any trust in the Federal Trade Commission to protect their rights. The hearing focused on HR 1946, a bill that would allow independent pharmacies to negotiate together with pharmacy benefit management companies (PBMs).  Read More…


Drug Costs Will Rise as FTC Approves Medco/Express Scripts Mega-Merger

Independent Pharmacists Denounce Deal as License to Price-Gouge the Consumer
April 2, 2011

FTC approval of a merger between two of the nation’s largest pharmacy benefits mangers (PBMs), Express Scripts Inc. and Medco Health Solutions Inc., will only add to the rising costs of prescription drugs, according to a group of independent pharmacists.  Read More…

Four Independent Pharmacies Sue HHS and CMS for Violating Medicare Part D Law By Allowing Drug Plans To Establish Cartels With Big Box Retailers
March 6, 2011
Four members of the Association of Community Pharmacists Congressional Network (ACPCN) have sued the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS). The lawsuit charges that CMS wrongfully permitted prescription drug plans (PDPs), run by Pharmacy Benefit Managers (PBMs), to create “preferred pharmacy networks.” The ACPCN coordinated lawsuit seeks to prevent CMS from approving network schemes that allow select pharmacies to entice enrollees through economic incentives, including lower copayments, while denying competing pharmacies access to the same terms and conditions as required by the Medicare Part D prescription program law. Read More…

Pharmacists Launch Campaign to Expose Unreasonable Price Markups on Prescription Drugs by Pharmacy Benefit Managers 
November 3, 2011
A national coalition of pharmacists and pharmacy owners today announced a public information campaign to expose the unjustifiably high prices of prescription drugs set by pharmacy benefits managers (PBMs), the unregulated, multibillion dollar industry that controls prescription health plans for more than 200 million Americans. Read more…

Pharmacists United for Truth and Transparency announce national campaign against PBM abuse
October 4, 2011
A growing group of pharmacy owners banded together this summer to form a coalition designed to take on PBM abuse, mandatory mail order and other threats to one of America’s oldest and most trusted professions, the pharmacist. They put out the word and quickly raised $100,000, hired a New York City consulting firm and became an incorporated entity: Pharmacists United for Truth and Transparency. Read more…